Literature DB >> 8285456

[Kawasaki disease; complications and clinical course. Apropos of 38 cases].

C Calvo Rey1, C Borque Andrés, F del Castillo Martín, A García Piñeiro, J García Hortelano, M García García, D Rubio Vidal, F Moreno Granados.   

Abstract

Between January 1978 and December 1991, 38 patients who fulfilled the CDC (Center for Disease Control) criteria for Kawasaki syndrome were admitted to our hospital. We reviewed the clinical data, laboratory tests, ECG and serial echocardiographic studies in order to establish the characteristics of the disease in our environment. There were 23 males and 15 females. The age at presentation ranged from 4 months to 10 years (mean 3.5 years). Extracardiac complications were as follows: arthritis in 12 patients, vesicular hydrops in 2, urinary tract infection in 1 and lymphocytic meningitis in 1. Cardiac involvement was frequent, with 35% of the patients being diagnosed with coronary pathologies (dilatation of coronary arteries in 9 and aneurysm formations in 4). The most usual location of these anomalies was in the left main coronary artery. By the end to the follow-up period, 71% of the lesions had disappeared. The time necessary for this regression was related to the size of the abnormalities. The high incidence of cardiac involvement make it necessary to follow these patients for a period of time in order to prevent or to treat the later occurring sequelae.

Entities:  

Mesh:

Year:  1993        PMID: 8285456

Source DB:  PubMed          Journal:  An Esp Pediatr        ISSN: 0302-4342


  2 in total

1.  Coronary artery ectasia in Egyptian patients with coronary artery disease.

Authors:  H M Waly; M A Elayda; V V Lee; G el-Said; G J Reul; R J Hall
Journal:  Tex Heart Inst J       Date:  1997

2.  An unusual pattern of arthritis in a child with Kawasaki syndrome.

Authors:  Ali Duzova; Rezan Topaloglu; Mehmet Keskin; Ugur Ozcelik; Gulten Secmeer; A Mazhar Tokgozoglu
Journal:  Clin Rheumatol       Date:  2004-01-08       Impact factor: 3.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.